COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1239: Articles 12381-12390  | Next

The COVID-19 Pandemic and Mental Health Concerns on Twitter in the United States
Zhang, S., Sun, L., Zhang, D., Li, P., Liu, Y., Anand, A., Xie, Z., Li, D.
10.1101/2021.08.23.21262489 — Posted: 2021-08-30
Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel
Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L. S., Haas, E., Milo, R., Alroy-Preis, S., Ash, N., Huppert, A.
10.1101/2021.08.24.21262423 — Posted: 2021-08-30 Discussion: Onsite
Analysis of alternative Covid-19 mitigation measures in school classrooms: an agent-based model of SARS-CoV-2 transmission
Woodhouse, M. J., Aspinall, W. P., Sparks, S. R., CoMMinS prject "COVID-19 Mapping and Mitigation in Schools"
10.1101/2021.08.30.21262826 — Posted: 2021-08-30
Vaccines alone are no silver bullets: a modeling study on the impact of efficient contact tracing on COVID-19 infection and transmission
Raja, D. B., Abdul Taib, N. A., Teo, A. K. J., Jayaraj, V. J., Ting, C. Y.
10.1101/2021.08.29.21262789 — Posted: 2021-08-30
Allosteric regulation of 3CL protease of SARS-CoV-2 and SARS-CoV observed in the crystal structure ensemble
Kidera, A., Moritsugu, K., Ekimoto, T., Ikeguchi, M.
10.1101/2021.08.29.458083 — Posted: 2021-08-30
Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis
Hirt, J., Janiaud, P., Hemkens, L. G.
10.1101/2021.08.20.21261687 — Posted: 2021-08-30 Discussion: Onsite
The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease
Melton, A., Doyle-Meyers, L. A., Blair, R. V., Midkiff, C., Melton, H. J., Russell-Lodrigue, K., Aye, P. P., Schiro, F., Fahlberg, M., Szeltner, D., Spencer, S., Beddingfield, B. J., Goff, K., Golden, N., Penney, T., Picou, B., Hensley, K., Chandler, K. E., Plante, J. A., Plante, K. S., Weaver, S. C., Roy, C. J., Hoxie, J. A., Gao, H., Montefiori, D. C., Mankowski, J. L., Bohm, R. P., Rappaport, J., Maness, N. J.
10.1101/2021.08.28.458047 — Posted: 2021-08-30
Predictive factors of response to 3rd dose of COVID-19 mRNA vaccine in kidney transplant recipients
Charmetant, X., ESPI, M., Barba, T., Ovize, A., Morelon, E., Thaunat, O.
10.1101/2021.08.23.21262293 — Posted: 2021-08-30
A machine learning approach for identification of gastrointestinal predictors for the risk of COVID-19 related hospitalization
Liptak, P., Banovcin, P., Rosolanka, R., Prokopic, M., Kocan, I., Ziacikova, I., Uhrik, P., Grendar, M., Hyrdel, R.
10.1101/2021.08.27.21262728 — Posted: 2021-08-30
Can tracking mobility be used as a public health tool against COVID-19 following the expiration of stay-at-home mandates?
Her, P. H., Saeed, S., Tram, K. H., Bhatnagar, S. R.
10.1101/2021.08.27.21262629 — Posted: 2021-08-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).